Skip to main content
. 2017 Sep 9;160(2):386–397. doi: 10.1093/toxsci/kfx192

Table 3.

KEGG Pathway Analysis of DEGs in the Brain

KEGG ID KEGG Pathway 0.3 nM PCB126 1.2 nM PCB126 Adjusted p-value
Upregulated genes
04020 Calcium signaling pathway 20 21 1.25E-06
04010 MAPK signaling pathway 23 23 4.44E-06
04330 Notch signaling pathway 12 5.61E-06
00310 Lysine degradation 8 8 2.36E-04
04012 ErbB signaling pathway 6 8 6.43E-03
04912 GnRH signaling pathway 12 6 7.04E-03
04320 Dorso-ventral axis formation 6 5 7.80E-03
04914 Progesterone-mediated oocyte maturation 8 6 9.52E-03
04068 FoxO signaling pathway 15 1.13E-02
Downregulated genes
00190 Oxidative phosphorylation 64 20 7.90E-61
03010 Ribosome 31 71 2.01E-46
01100 Metabolic pathways 124 4.93E-13
01200 Carbon metabolism 23 7.18E-04
04512 ECM-receptor interaction 15 3.04E-03
00480 Glutathione metabolism 8 3.67E-03
01212 Fatty acid metabolism 11 1.08E-02
00020 Citrate cycle (TCA cycle) 5 1.27E-02

KEGG pathway analysis of DEGs from 0.3 and 1.2 nM PCB groups was conducted using gProfiler and the enriched KEGG terms were compared using gCocoa. KEGG pathways and the number of up and downregulated DEGs associated with each KEGG term from both treatments are listed below. The list of gene names associated with each pathway is provided in Supplementary Material (PathwayAnalysis_up.xlsx; PathwayAnalysis_down.xlsx). A dash (—) indicates that the KEGG term was not significantly enriched in that exposure group.